Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03728361 |
|---|---|
| Brief Title: | Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer |
| First Submitted : | October 29, 2018 |
| First Submitted that Met QC Criteria : | October 30, 2018 |
| First Posted : | November 2, 2018 |
| Last Update Submitted that Met QC Criteria : | April 27, 2022 |
| Last Update Posted : | April 29, 2022 |